{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:02Z","timestamp":1792640642991,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CORTAHF"},{"name":"Heart Initiative"},{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["IDUB.A46B.24.002"],"award-info":[{"award-number":["IDUB.A46B.24.002"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Strategy of the Wroclaw Medical University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Hierarchical composite endpoints (HCE) analysed using generalized pairwise comparisons (GPCs) have been increasingly adopted in cardiovascular trials. Stratified, but not covariate-adjusted, win statistics have frequently been presented. We apply methods to a post hoc HCE for the randomized 100-patient CORTAHF pilot trial of short-term corticosteroid therapy in acute heart failure (AHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The HCE comprised 90-day death, 90-day HF readmission, 30-day worsening HF, and 30-day change in EQ-5D visual analogue scale (EQ-VAS) score from baseline. Win statistics and patient ranks from worst to best outcome were derived from GPC. These ranks were used to produce site-stratified and baseline EQ-VAS-adjusted win odds. Analysis of individual components suggested beneficial prednisone effects on 90-day HF readmission and 30-day worsening heart failure adverse events, with little effect on 30-day change in EQ-VAS. The win ratio and win odds were 1.82 and 1.71, respectively (both P &amp;lt; 0.05), with 10% ties remaining after most comparisons were resolved at the last tier. HF readmission contributed most to the overall win difference of 26.1%. Stratification and baseline covariate adjustment using patients\u2019 ranks were feasible but, in this example, did not substantially alter the estimated win odds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients\u2019 ranks can be derived from GPC and used to estimate stratified and covariate-adjusted win statistics as well as to visualize the treatment effect. Use of a well-constructed HCE in a small pilot trial should be considered; a positive signal may support further examination of the treatment. A full analysis can aid in interpretation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvag089","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:35:39Z","timestamp":1791286539000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis and interpretation of a hierarchical outcome in a small pilot randomized trial: an example in the CORTAHF trial"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-7722","authenticated-orcid":false,"given":"Jan","family":"Biegus","sequence":"first","affiliation":[{"name":"Department of Cardiology, Clinical Department of Intensive Cardiac Care, Faculty of Medicine, Institute of Heart Diseases, Wroclaw Medical University , Borowska 213, Wroclaw 50-556 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-9758","authenticated-orcid":false,"given":"Christopher","family":"Edwards","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , 1426 E NC Highway 54, Suite B, Durham, NC 27713 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Cotter","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , 1426 E NC Highway 54, Suite B, Durham, NC 27713 ,","place":["USA"]},{"name":"INSERM UMR-S 942 (MASCOT), Universit\u00e9 Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Heart Initiative , Durham, NC 27713 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonathan","family":"Freund","sequence":"additional","affiliation":[{"name":"IMProving Emergency Care FHU, Universit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Emergency Department and Service Mobile D\u2019Urgence et de R\u00e9animation (SMUR), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) , 75013 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-4415","authenticated-orcid":false,"given":"Adriaan A","family":"Voors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Centre Groningen , 9713 GZ Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-1509","authenticated-orcid":false,"given":"Koji","family":"Takagi","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , 1426 E NC Highway 54, Suite B, Durham, NC 27713 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-7064","authenticated-orcid":false,"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Department of Intensive Cardiac Care, Faculty of Medicine, Institute of Heart Diseases, Wroclaw Medical University , Borowska 213, Wroclaw 50-556 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-0332","authenticated-orcid":false,"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital , 124 62 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-3628","authenticated-orcid":false,"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"Emergency Institute for Cardiovascular Diseases \u2018Prof. C.C. Iliescu\u2019, University of Medicine \u2018Carol Davila\u2019 , 022322 Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-7871","authenticated-orcid":false,"given":"Matteo","family":"Pagnesi","sequence":"additional","affiliation":[{"name":"Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , 25123 Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), St Antoine Hospital, APHP , 75012 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L","family":"Mann","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine , St. Louis, 63110 MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-6449","authenticated-orcid":false,"given":"Beth","family":"Davison","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc , 1426 E NC Highway 54, Suite B, Durham, NC 27713 ,","place":["USA"]},{"name":"INSERM UMR-S 942 (MASCOT), Universit\u00e9 Paris Cit\u00e9 , 75010 Paris ,","place":["France"]},{"name":"Heart Initiative , Durham, NC 27713 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026102123313199800_pvag089-B1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/ejhf.2853","article-title":"The win ratio method in heart failure trials: lessons learnt from EMPULSE","volume":"25","author":"Pocock","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026102123313199800_pvag089-B2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.124.070251","article-title":"Hierarchical composite outcomes and win ratio methods in cardiovascular trials: a review and consequent guidance","volume":"151","author":"Gregson","year":"2025","journal-title":"Circulation"},{"key":"2026102123313199800_pvag089-B3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"2026102123313199800_pvag089-B4","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1093\/eurheartj\/ehae647","article-title":"The win ratio in cardiology trials: lessons learnt, new developments, and wise future use","volume":"45","author":"Pocock","year":"2024","journal-title":"Eur Heart J"},{"key":"2026102123313199800_pvag089-B5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jacc.2023.06.047","article-title":"Generalized pairwise comparisons to assess treatment effects: JACC review topic of the week","volume":"82","author":"Verbeeck","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102123313199800_pvag089-B6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ehf2.15074","article-title":"Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure","volume":"12","author":"Abraham","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026102123313199800_pvag089-B7","doi-asserted-by":"crossref","DOI":"10.4081\/cardio.2024.33","article-title":"Using multiple primary endpoints in clinical trials with a focus on heart failure","volume":"2","author":"Anker","year":"2024","journal-title":"Global Cardiol"},{"key":"2026102123313199800_pvag089-B8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"2026102123313199800_pvag089-B9","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/ejhf.3452","article-title":"Burst steroid therapy for acute heart failure: the CORTAHF randomized, open-label, pilot trial","volume":"26","author":"Cotter","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026102123313199800_pvag089-B10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ehf2.15235","article-title":"Burst steroid therapy and quality of life in patients with acute heart failure: insights from the CORTAHF trial","volume":"12","author":"Pagnesi","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026102123313199800_pvag089-B11","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/ehf2.14930","article-title":"Corticosteroid burst therapy in patients with acute heart failure: design of the CORTAHF pilot study","volume":"11","author":"Cotter","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026102123313199800_pvag089-B12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pst.2251","article-title":"Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes","volume":"22","author":"Dong","year":"2023","journal-title":"Pharm Stat"},{"key":"2026102123313199800_pvag089-B13","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1002\/sim.8388","article-title":"Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints","volume":"38","author":"Verbeeck","year":"2019","journal-title":"Stat Med"},{"key":"2026102123313199800_pvag089-B14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/10543406.2020.1730873","article-title":"Evaluation of inferential methods for the net benefit and win ratio statistics","volume":"30","author":"Verbeeck","year":"2020","journal-title":"J Biopharm Stat"},{"key":"2026102123313199800_pvag089-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i09","article-title":"Sanon: an R package for stratified analysis with nonparametric covariable adjustment","volume":"67","author":"Kawaguchi","year":"2015","journal-title":"J Stat Softw"},{"key":"2026102123313199800_pvag089-B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3329\/jsr.v58i1.75411","article-title":"Randomization-based covariance adjustment of win ratios and win odds for randomized multi-visit studies with ordinal outcomes","volume":"58","author":"Weideman","year":"2024","journal-title":"J Stat Res"},{"key":"2026102123313199800_pvag089-B17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pst.1977","article-title":"The win ratio: impact of censoring and follow-up time and use with nonproportional hazards","volume":"19","author":"Dong","year":"2020","journal-title":"Pharm Stat"},{"key":"2026102123313199800_pvag089-B18","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2025"},{"key":"2026102123313199800_pvag089-B19","doi-asserted-by":"crossref","unstructured":"Weideman \u00a0AMK, Kowalewski \u00a0EK, Koch \u00a0GG. winr: randomization-based covariance adjustment of win statistics. 2024. https:\/\/CRAN.R-project.org\/package=winr","DOI":"10.32614\/CRAN.package.winr"},{"key":"2026102123313199800_pvag089-B20","unstructured":"Cui \u00a0Y, Huang \u00a0B. WINS: the R WINS package. 2025. https:\/\/CRAN.R-project.org\/package=WINS"},{"key":"2026102123313199800_pvag089-B21","unstructured":"Cui \u00a0Y, Huang \u00a0B. Introduction to the R package WINS: package vignette. 2025. https:\/\/cran.r-project.org\/web\/packages\/WINS\/vignettes\/vignette.pdf"},{"key":"2026102123313199800_pvag089-B22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pst.1763","article-title":"A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components","volume":"15","author":"Dong","year":"2016","journal-title":"Pharm Stat"},{"key":"2026102123313199800_pvag089-B23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/biostatistics\/kxv032","article-title":"Large sample inference for a win ratio analysis of a composite outcome based on prioritized components","volume":"17","author":"Bebu","year":"2016","journal-title":"Biostatistics"},{"key":"2026102123313199800_pvag089-B24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/10543406.2017.1397007","article-title":"The stratified win ratio","volume":"28","author":"Dong","year":"2018","journal-title":"J Biopharm Stat"},{"key":"2026102123313199800_pvag089-B25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1198\/sbr.2010.10007","article-title":"Stratified multivariate Mann\u2013Whitney estimators for the comparison of two treatments with randomization based covariance adjustment","volume":"3","author":"Kawaguchi","year":"2011","journal-title":"Stat Biopharm Res"},{"key":"2026102123313199800_pvag089-B26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1161\/CIRCULATIONAHA.123.067786","article-title":"Win ratio: a seductive but potentially misleading method for evaluating evidence from clinical trials","volume":"149","author":"Butler","year":"2024","journal-title":"Circulation"},{"key":"2026102123313199800_pvag089-B27","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1093\/eurheartj\/ehag511","article-title":"Great debate: medical treatment of heart failure with reduced ejection fraction will rely on four foundational drugs","volume":"47","author":"Cleland","year":"2026","journal-title":"Eur Heart J\u00a0"},{"key":"2026102123313199800_pvag089-B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCHEARTFAILURE.109.926030","article-title":"A global rank end point for clinical trials in acute heart failure","volume":"3","author":"Felker","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026102123313199800_pvag089-B29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7","article-title":"Combining mortality and longitudinal measures in clinical trials","volume":"18","author":"Finkelstein","year":"1999","journal-title":"Stat Med"},{"key":"2026102123313199800_pvag089-B30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cardfail.2024.09.002","article-title":"The effects of burst steroid therapy on short-term decongestion in acute heart failure patients with pro-inflammatory activation: a post hoc analysis of the CORTAHF randomized, open-label, pilot trial","volume":"31","author":"Biegus","year":"2025","journal-title":"J Card Fail"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag089\/71646563\/pvag089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag089\/71646563\/pvag089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:31:45Z","timestamp":1792639905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article\/doi\/10.1093\/ehjcvp\/pvag089\/8872128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag089","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"pvag089"}}